Michael Blough
Tracked across 1 events · 7 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Optimi Health, a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, announced the appointment of Michael Blough, Ph.D., as its Chief Clinical Development Officer, a newly created position. Dr. Blough has worked with Optimi on…
Impact: He was appointed Chief Clinical Development Officer and will oversee Optimi's clinical development strategy and trials. His extensive psychedelic trial experience is expected to advance the company's programs.
Sep 22, 2026 · 7 articles
85
Optimi Health appointed Michael BloughOptimi Health Appoints...
ERGEN INTELLIGENCE
Track Michael Blough live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard